Search
Iteos Therapeutics Inc
ITOSAdd to Watchlist
10.150USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
388.46MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
4
analysts
Hold
Current Rating
10.349
Target Price
+1.96%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Iteos Therapeutics Inc
ITOS
4
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
How have Iteos Therapeutics IncITOS's recent earnings per share performed?
The market expectation was USD -1.81, while Iteos Therapeutics IncITOS's earnings per share (EPS) for the previous quarter was USD -0.80. EPS for the next quarter is expected at USD -1.15.
What is the analyst rating for Iteos Therapeutics Inc?
Based on the ratings of Iteos Therapeutics Inc's stock from 4 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.